Zelira Therapeutics Limited (ASX:ZLD)
Australia · Delayed Price · Currency is AUD 0.5000
0.00 (0.00%)
Feb 27, 2026, 3:55 PM AEST
Zelira Therapeutics Market Cap
Zelira Therapeutics has a market cap or net worth of 5.95 million as of October 9, 2026. It is the 45,750th most valuable company in the world and the 1,502nd biggest in Australia. Its market cap has increased by 11.54% in one year.
Market Cap
5.95M
Enterprise Value
8.25M
Revenue
656.00
Global Rank
Country Rank
#1,502 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since November 22, 2016, Zelira Therapeutics's market cap has decreased from 15.39M to 5.95M, a decrease of -61.35%. That is a compound annual growth rate of -9.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 5.95M | 17.65% |
| Dec 30, 2025 | 5.06M | -28.13% |
| Dec 31, 2024 | 7.04M | -31.11% |
| Dec 29, 2023 | 10.21M | 6.63% |
| Dec 30, 2022 | 9.58M | -77.35% |
| Dec 31, 2021 | 42.28M | -61.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 14.53M |
| AdAlta | 9.64M |
| Invex Therapeutics | 8.27M |
| Vectus Biosystems | 6.53M |
| Acrux | 6.49M |
| Bio-Gene Technology | 6.13M |
| Biotron | 5.57M |
| Tissue Repair | 5.14M |